NRG GU007

Primary Category:

Radiation Oncology

Disease Category:

Genitourinary, Prostate

Status:

Temporarily Closed

Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I)

 

GU007 is temporarily closed to accrual effective immediately, 03/05/20, because the first dose level of the phase I portion has enrolled the required number of patients. The trial will be temporarily closed for approximately 2 months for a protocol-specified toxicity analysis. A broadcast regarding reopening will be sent when the protocol-specified toxicity analysis is complete.